← Back to legal documents

Intellectual Property Notice

Last updated: July 15, 2026

Ownership of App Content

All original text, design, code, and data structures within Psych Algo (Education) (the "App") that are not attributed to a third party are © 2026 Jasmin Flores. All rights reserved, except as expressly licensed.

No Reproduction of Third-Party Copyrighted Works

This App does not reproduce, copy, or republish text, tables, dosing charts, decision trees, or other content from any copyrighted publication, including (without limitation):

All clinical summaries in the App were independently written to reflect general, widely-taught prescribing concepts. These works are listed on the App's References screen solely as recommended sources for further reading and verification — not as sources of copied content.

Trademarks

Any product names, book titles, publisher names, or organization names referenced in the App are trademarks or registered trademarks of their respective owners. Reference to these names is for identification and citation purposes only and does not imply any affiliation with, sponsorship by, or endorsement from those trademark owners.

DSM-5-TR Terminology

Diagnostic category names and codes referenced in the App (e.g., "Major Depressive Disorder," diagnostic codes) are used descriptively, for educational and reference purposes, consistent with their function as clinical terminology. The DSM-5-TR itself, including its full diagnostic criteria and text, remains the copyrighted work of the American Psychiatric Association and is not reproduced here.

User Content

The App does not currently support user accounts, submissions, or cloud-synced content; there is no user-generated content collected or stored by the App.

Reporting Concerns

If you believe any content within this App infringes your intellectual property rights, please contact info@solunahc.com with enough detail to identify the specific content and your claimed rights.

This is a template, not legal advice. Copyright and fair-use analysis is fact-specific. Please have this notice reviewed by an attorney familiar with intellectual property and healthcare publishing before public release, particularly regarding use of DSM-5-TR terminology and diagnostic codes.